{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:56:50Z","timestamp":1780714610064,"version":"3.54.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.earlhumdev.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:21:29Z","timestamp":1536013289000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["New diagnostic modalities and emerging treatments for neonatal bone disease"],"prefix":"10.1016","volume":"126","author":[{"given":"Stephanie A.","family":"Borg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.earlhumdev.2018.08.014_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000243297","article-title":"Human neonatal hypocalcemia","volume":"58","author":"Salle","year":"1990","journal-title":"Biol. Neonate"},{"issue":"6","key":"10.1016\/j.earlhumdev.2018.08.014_bb0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/adc.62.6.580","article-title":"Plasma thyrocalcitonin and parathyroid hormone concentrations in early neonatal hypocalcaemia","volume":"62","author":"Romagnoli","year":"1987","journal-title":"Arch. Dis. Child."},{"issue":"10","key":"10.1016\/j.earlhumdev.2018.08.014_bb0015","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/adc.57.10.754","article-title":"Control of vitamin D metabolism in preterm infants: feto-maternal relationships","volume":"57","author":"Delvin","year":"1982","journal-title":"Arch. Dis. Child."},{"issue":"Suppl. 2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0020","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1542\/peds.2006-2023F","article-title":"Calcium and vitamin D: what is known about the effects on growing bone","volume":"119","author":"Demay","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0025","first-page":"109","article-title":"Matrix vesicle calcification: review and update","volume":"3","author":"Anderson","year":"1985","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.earlhumdev.2018.08.014_bb0030","first-page":"801","article-title":"Catabolic and anabolic actions of parathyroid hormone on the skeleton","volume":"34","author":"Silva","year":"2011","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.earlhumdev.2018.08.014_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9378(16)39048-2","article-title":"The estimation of fetal maturity by roentgen studies of osseous development; preliminary report","volume":"60","author":"Christie","year":"1950","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiology.159.2.3515425","article-title":"Epiphyseal ossification centers in the assessment of fetal maturity: sonographic correlation with the amniocentesis lung profile","volume":"159","author":"Mahony","year":"1986","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1203\/00006450-199911000-00015","article-title":"Bone and collagen markers in preterm infants: relationship with growth and bone mineral content over the first 10 weeks of life","volume":"46","author":"Crofton","year":"1999","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pedneo.2016.05.005","article-title":"Bone mineral density according to dual energy X-ray absorptiometry is associated with serial serum alkaline phosphatase level in extremely low birth weight infants at discharge","volume":"58","author":"Lee","year":"2017","journal-title":"Pediatr. Neonatol."},{"issue":"8","key":"10.1016\/j.earlhumdev.2018.08.014_bb0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/jp.2015.64","article-title":"Parathyroid hormone as a marker for metabolic bone disease of prematurity","volume":"35","author":"Moreira","year":"2015","journal-title":"J. Perinatol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","article-title":"New approaches for interpreting projected bone densitometry data","volume":"7","author":"Carter","year":"1992","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.earlhumdev.2018.08.014_bb0065","article-title":"Postnatal changes in tibial bone speed of sound of preterm and term infants during infancy","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0070","doi-asserted-by":"crossref","first-page":"F161","DOI":"10.1136\/fn.80.3.F161","article-title":"Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants","volume":"80","author":"Backstrom","year":"1999","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0075","first-page":"575","article-title":"The long-term effect of early mineral, vitamin D, and breast milk intake on bone mineral status in 9- to 11-year-old children born prematurely","volume":"29","author":"Backstrom","year":"1999","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"1","key":"10.1016\/j.earlhumdev.2018.08.014_bb0080","doi-asserted-by":"crossref","first-page":"F44","DOI":"10.1136\/fn.73.1.F44","article-title":"Sodium glycerophosphate in the treatment of neonatal hypophosphataemia","volume":"73","author":"Costello","year":"1995","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/adc.2006.106120","article-title":"Unexplained fractures in infancy: looking for fragile bones","volume":"92","author":"Bishop","year":"2007","journal-title":"Arch. Dis. Child."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jbmr.2835","article-title":"Bone material properties in osteogenesis imperfecta","volume":"31","author":"Bishop","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/jbmr.258","article-title":"Evolution of the radiographic appearance of the metaphyses over the first year of life in type V osteogenesis imperfecta: clues to pathogenesis","volume":"26","author":"Arundel","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0100","doi-asserted-by":"crossref","unstructured":"Breslau-Siderius EJ, Engelbert RH, Pals G, van der Sluijs JA. Bruck syndrome: a rare combination of bone fragility and multiple congenital joint contractures. J. Pediatr. Orthop. B Jan 1998;7(1):35\u201338.","DOI":"10.1097\/01202412-199801000-00006"},{"issue":"10","key":"10.1016\/j.earlhumdev.2018.08.014_bb0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s002470050465","article-title":"Bruck syndrome: neonatal presentation and natural course in three patients","volume":"28","author":"Leroy","year":"1998","journal-title":"Pediatr. Radiol."},{"issue":"1","key":"10.1016\/j.earlhumdev.2018.08.014_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/dds371","article-title":"Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen","volume":"22","author":"Schwarze","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jmedgenet-2017-104899","article-title":"P4HB recurrent missense mutation causing Cole-Carpenter syndrome","volume":"55","author":"Balasubramanian","year":"2018","journal-title":"J. Med. Genet."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2015.01.002","article-title":"Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta","volume":"96","author":"Garbes","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ajhg.2014.12.027","article-title":"Cole-carpenter syndrome is caused by a heterozygous missense mutation in P4HB","volume":"96","author":"Rauch","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jmedgenet-2013-101567","article-title":"Mutations in WNT1 are a cause of osteogenesis imperfecta","volume":"50","author":"Fahiminiya","year":"2013","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","article-title":"Mutations in WNT1 cause different forms of bone fragility","volume":"92","author":"Keupp","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.earlhumdev.2018.08.014_bb0140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/humu.21475","article-title":"COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta","volume":"32","author":"Lindahl","year":"2011","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0145","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1172\/JCI22760","article-title":"A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders","volume":"115","author":"Gensure","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ajmg.a.36916","article-title":"CRTAP mutation in a patient with Cole-Carpenter syndrome","volume":"167A","author":"Balasubramanian","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"9","key":"10.1016\/j.earlhumdev.2018.08.014_bb0155","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/humu.22362","article-title":"Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations","volume":"34","author":"Barnes","year":"2013","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","article-title":"Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta","volume":"86","author":"Christiansen","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.earlhumdev.2018.08.014_bb0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ajhg.2015.04.021","article-title":"Recessive osteogenesis imperfecta caused by missense mutations in SPARC","volume":"96","author":"Mendoza-Londono","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0170","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajhg.2012.02.026","article-title":"Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish","volume":"90","author":"Asharani","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/hmg\/ddu471","article-title":"A polyadenylation site variant causes transcript-specific BMP1 deficiency and frequent fractures in children","volume":"24","author":"Fahiminiya","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.earlhumdev.2018.08.014_bb0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00223-013-9799-2","article-title":"Hyperosteoidosis and hypermineralization in the same bone: bone tissue analyses in a boy with a homozygous BMP1 mutation","volume":"93","author":"Hoyer-Kuhn","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"12","key":"10.1016\/j.earlhumdev.2018.08.014_bb0185","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/ajmg.a.37958","article-title":"Phenotypic variability in patients with osteogenesis imperfecta caused by BMP1 mutations","volume":"170","author":"Pollitt","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bone.2017.11.013","article-title":"Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice","volume":"107","author":"Rauch","year":"2018","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MCD.0b013e32836032f0","article-title":"Genotype-phenotype study in type V osteogenesis imperfecta","volume":"22","author":"Balasubramanian","year":"2013","journal-title":"Clin. Dysmorphol."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","article-title":"A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus","volume":"91","author":"Semler","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","article-title":"A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V","volume":"91","author":"Cho","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","article-title":"Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta","volume":"88","author":"Becker","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.earlhumdev.2018.08.014_bb0215","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajhg.2010.05.016","article-title":"Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta","volume":"87","author":"Lapunzina","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ajhg.2015.08.009","article-title":"Genetic defects in TAPT1 disrupt ciliogenesis and cause a complex lethal osteochondrodysplasia","volume":"97","author":"Symoens","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.earlhumdev.2018.08.014_bb0225","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","article-title":"DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum","volume":"27","author":"Bardai","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.earlhumdev.2018.08.014_bb0230","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jmedgenet-2012-101142","article-title":"Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation","volume":"49","author":"Shaheen","year":"2012","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.earlhumdev.2018.08.014_bb0235","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1210\/jc.2016-3766","article-title":"Phenotypic spectrum in osteogenesis imperfecta due to mutations in TMEM38B: unraveling a complex cellular defect","volume":"102","author":"Webb","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0240","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1750-1172-8-154","article-title":"Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans","volume":"8","author":"Symoens","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11920","article-title":"MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta","volume":"7","author":"Lindert","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0250","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jmedgenet-2017-104999","article-title":"FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta","volume":"55","author":"Doyard","year":"2018","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.earlhumdev.2018.08.014_bb0255","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ajhg.2015.04.017","article-title":"Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects","volume":"96","author":"Munns","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0260","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1086\/497706","article-title":"Clinical and molecular findings in osteoporosis-pseudoglioma syndrome","volume":"77","author":"Ai","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.mol.0000162326.62419.e4","article-title":"Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass","volume":"16","author":"Ferrari","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0270","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0275","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1359\/JBMR.050101","article-title":"Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children","volume":"20","author":"Hartikka","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bone.2016.10.023","article-title":"Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfecta","volume":"94","author":"Balasubramanian","year":"2017","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.earlhumdev.2018.08.014_bb0285","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ejmg.2015.11.005","article-title":"Neuroblastoma Amplified Sequence (NBAS) mutation in recurrent acute liver failure: confirmatory report in a sibship with very early onset, osteoporosis and developmental delay","volume":"58","author":"Capo-Chichi","year":"2015","journal-title":"Eur. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0290","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1086\/381715","article-title":"Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann\/Schwartz-Jampel type 2 syndrome","volume":"74","author":"Dagoneau","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.earlhumdev.2018.08.014_bb0295","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00198-017-4031-2","article-title":"Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta","volume":"28","author":"Bardai","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"16","key":"10.1016\/j.earlhumdev.2018.08.014_bb0300","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","article-title":"PLS3 mutations in X-linked osteoporosis with fractures","volume":"369","author":"van Dijk","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/JMDH.S113483","article-title":"Managing the patient with osteogenesis imperfecta: a multidisciplinary approach","volume":"10","author":"Marr","year":"2017","journal-title":"J. Multidiscip. Healthc."},{"issue":"1","key":"10.1016\/j.earlhumdev.2018.08.014_bb0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","article-title":"Denosumab: anti-RANKL antibody","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0315","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13023-014-0145-1","article-title":"Two years' experience with denosumab for children with osteogenesis imperfecta type VI","volume":"9","author":"Hoyer-Kuhn","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.earlhumdev.2018.08.014_bb0320","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/jbmr.3143","article-title":"BPS804 anti-sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized phase 2a trial","volume":"32","author":"Glorieux","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.earlhumdev.2018.08.014_bb0325","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrendo.2013.154","article-title":"Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches","volume":"9","author":"Canalis","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0330","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jbmr.2776","article-title":"Sclerostin antibody treatment improves the bone phenotype of Crtap mice, a model of recessive osteogenesis imperfecta","volume":"31","author":"Grafe","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.earlhumdev.2018.08.014_bb0335","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4161\/auto.5.8.10168","article-title":"Autophagy eliminates a specific species of misfolded procollagen and plays a protective role in cell survival against ER stress","volume":"5","author":"Ishida","year":"2009","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0340","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","article-title":"Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta","volume":"97","author":"Horwitz","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0345","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","article-title":"The role of phosphatases in the initiation of skeletal mineralization","volume":"93","author":"Millan","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.earlhumdev.2018.08.014_bb0350","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jc.2015-3462","article-title":"Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia","volume":"101","author":"Whyte","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.earlhumdev.2018.08.014_bb0355","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0360","first-page":"180","article-title":"Working group on calcium M. Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004)","volume":"69","author":"Mallet","year":"2008","journal-title":"Horm. Res."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0365","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0167-4889(98)00140-2","article-title":"Disorders of the calcium-sensing receptor","volume":"1448","author":"Thakker","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.earlhumdev.2018.08.014_bb0370","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1101\/gad.277137.115","article-title":"Genetic insights into the mechanisms of Fgf signaling","volume":"30","author":"Brewer","year":"2016","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.earlhumdev.2018.08.014_bb0375","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/dvdy.24479","article-title":"Achondroplasia: development, pathogenesis, and therapy","volume":"246","author":"Ornitz","year":"2017","journal-title":"Dev. Dyn."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0380","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/302000","article-title":"Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome","volume":"63","author":"Wilkin","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0385","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.earlhumdev.2018.08.014_bb0390","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.earlhumdev.2018.08.014_bb0395","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.10.014","article-title":"Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia","volume":"91","author":"Lorget","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.earlhumdev.2018.08.014_bb0400","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2014-1914","article-title":"Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene","volume":"156","author":"Matsushita","year":"2015","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.earlhumdev.2018.08.014_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081569","article-title":"Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia","volume":"8","author":"Matsushita","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.earlhumdev.2018.08.014_bb0410","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1093\/hmg\/dds181","article-title":"Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia","volume":"21","author":"Xie","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.earlhumdev.2018.08.014_bb0415","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.earlhumdev.2018.08.014_bb0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcdb.2015.12.013","article-title":"Granting immunity to FOP and catching heterotopic ossification in the act","volume":"49","author":"Kaplan","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.earlhumdev.2018.08.014_bb0425","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) mutation","volume":"31","author":"Chakkalakal","year":"2016","journal-title":"J. Bone Miner. Res."}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378218305528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378218305528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T18:53:26Z","timestamp":1717268006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378218305528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":85,"alternative-id":["S0378378218305528"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2018.08.014","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New diagnostic modalities and emerging treatments for neonatal bone disease","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}